… imaging or therapy, they have attractive features for brain delivery. However, the greatest
limitations for the use of MRI/MPI for imaging … for targeting, imaging and therapy of primary and …

… -based therapy. To ensure robust information during the development of nanomaterials for
PET/SPECT imaging and/or radionuclide therapy, … products for in vivo imaging and/or therapy. …

… Although infection imaging may seem to be a tangent from the primary focus of this review,
it is exceptionally important for patients with underlying cancers. Many patients with cancer …

… The primary endpoint was PFS by central review. Following randomisation of 185 patients
(91% iCCA; 124 patients to ivosidenib and 61 to placebo), the primary endpoint of PFS was …

… Besides primary tumors, the magnetic- responsive nanocarriers have also demonstrated
high potential for treating metastatic tumors (eg, lung metastasis) 109 . Furthermore, the …

… targeted delivery can better focus the therapeutic agent to the target site, and reduce
systemic side effects; (3) targeted … programming of the primary sequence of amino acids [117,118]. …

… therapy. This includes recent advances in multimodality imaging, image-guided therapy, and
combination therapy. … future development of medical imaging and cancer therapy. However, …

… mitochondria-targeted photothermal cancer therapy without ROS … NIR-II image-guided
photothermal therapy. This report … -targeted cell imaging, in vivo NIR-II osteosarcoma imaging …

… For example, by incorporating Glu or Orn into the primary structure of Q11 peptide, the … for
designing acid-labile SAP nanoparticles for targeted imaging or therapy (Figure 4A). Jan et al. (…

… the mainstay of therapy for … therapy for most patients with advanced NETs. Second line
treatments for NET, depending on the primary tumour site, include molecularly targeted therapies …